- Home
- MED vs CNTB Comparison
MED vs CNTB Comparison
Compare MED & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MED | CNTB |
|---|---|---|
| Founded | 1980 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 122.8M | 140.4M |
| IPO Year | 1996 | 2020 |
Fundamental Metrics
Financial Performance| Metric | MED | CNTB |
|---|---|---|
| Price | $12.55 | $1.97 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $12.00 | $8.67 |
| AVG Volume (30 Days) | 119.1K | ★ 719.9K |
| Earning Date | 05-04-2026 | 08-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $934,842,000.00 | $64,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.22 | $1.23 |
| 52 Week High | $14.67 | $3.82 |
Technical Indicators
Market Signals| Indicator | MED | CNTB |
|---|---|---|
| Relative Strength Index (RSI) | 62.36 | 47.75 |
| Support Level | $12.24 | $2.08 |
| Resistance Level | $13.39 | $2.74 |
| Average True Range (ATR) | 0.44 | 0.24 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 69.10 | 12.18 |
Price Performance
Historical ComparisonAbout MED MEDIFAST INC
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.